RUA Life Sciences plc (AIM:RUA)

RUA Life Sciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	10	7	6	11	11	31
Market Cap Growth	29.17%	33.33%	-51.11%	5.10%	-65.37%	209.77%
Enterprise Value	7	5	6	9	6	31
Last Close Price	0.15	0.12	0.09	0.52	0.49	1.42
PE Ratio	9619.34	7447.23	-	-	-	-
PS Ratio	2.34	1.81	2.55	5.24	6.69	20.54
PB Ratio	1.30	1.01	0.78	2.44	1.65	3.69
P/TBV Ratio	1.45	1.13	0.86	2.92	1.89	4.11
EV/Sales Ratio	1.74	1.21	2.53	4.30	3.99	20.09
EV/EBITDA Ratio	17.89	12.39	-	-	-	-
EV/FCF Ratio	-25.54	-	-	-	-	-
Debt / Equity Ratio	0.14	0.14	0.05	0.10	0.05	0.05
Debt / EBITDA Ratio	2.57	2.57	-	-	-	-
Asset Turnover	0.47	0.47	0.32	0.33	0.18	0.24
Inventory Turnover	2.17	2.17	4.92	4.40	3.39	4.72
Quick Ratio	4.23	4.23	8.40	4.60	7.32	6.17
Current Ratio	4.91	4.91	9.01	5.20	8.23	6.67
Return on Equity (ROE)	0.01%	0.01%	-24.27%	-35.55%	-27.40%	-26.92%
Return on Assets (ROA)	-0.14%	-0.14%	-17.51%	-21.69%	-16.54%	-15.33%
Return on Capital Employed (ROCE)	-0.20%	-0.20%	-25.40%	-43.90%	-33.10%	-17.10%
Earnings Yield	0.01%	0.01%	-25.78%	-17.53%	-19.02%	-4.62%
FCF Yield	-2.92%	-3.77%	-24.76%	-13.96%	-29.96%	-6.48%
Buyback Yield / Dilution	-85.00%	-85.00%	-51.21%	-	-25.36%	-20.50%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.